Amalgamated Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$64K Hold
7,155
﹤0.01% 1776
2025
Q1
$54K Buy
7,155
+442
+7% +$3.34K ﹤0.01% 1788
2024
Q4
$50K Hold
6,713
﹤0.01% 1837
2024
Q3
$51K Hold
6,713
﹤0.01% 1840
2024
Q2
$41K Buy
6,713
+366
+6% +$2.24K ﹤0.01% 1898
2024
Q1
$32K Sell
6,347
-17,910
-74% -$90.3K ﹤0.01% 1982
2023
Q4
$145K Sell
24,257
-1,889
-7% -$11.3K ﹤0.01% 1890
2023
Q3
$185K Hold
26,146
﹤0.01% 1815
2023
Q2
$184K Buy
26,146
+1,926
+8% +$13.6K ﹤0.01% 1851
2023
Q1
$202K Sell
24,220
-3,681
-13% -$30.7K ﹤0.01% 1799
2022
Q4
$320K Hold
27,901
﹤0.01% 1668
2022
Q3
$352K Buy
27,901
+328
+1% +$4.14K ﹤0.01% 1594
2022
Q2
$292K Buy
27,573
+4,481
+19% +$47.5K ﹤0.01% 1706
2022
Q1
$375K Sell
23,092
-977
-4% -$15.9K ﹤0.01% 1674
2021
Q4
$333K Sell
24,069
-93
-0.4% -$1.29K ﹤0.01% 1765
2021
Q3
$347K Sell
24,162
-1,687
-7% -$24.2K ﹤0.01% 1776
2021
Q2
$409K Buy
25,849
+2,809
+12% +$44.4K ﹤0.01% 1740
2021
Q1
$234K Sell
23,040
-1,374
-6% -$14K 0.01% 1402
2020
Q4
$182K Buy
24,414
+138
+0.6% +$1.03K 0.01% 1463
2020
Q3
$83K Buy
24,276
+2,228
+10% +$7.62K ﹤0.01% 1427
2020
Q2
$105K Sell
22,048
-1,490
-6% -$7.1K ﹤0.01% 1392
2020
Q1
$47K Buy
23,538
+3,497
+17% +$6.98K ﹤0.01% 1575
2019
Q4
$69K Buy
20,041
+664
+3% +$2.29K ﹤0.01% 1770
2019
Q3
$56K Sell
19,377
-140
-0.7% -$405 ﹤0.01% 1701
2019
Q2
$74K Buy
19,517
+3,749
+24% +$14.2K ﹤0.01% 1718
2019
Q1
$128K Buy
15,768
+596
+4% +$4.84K ﹤0.01% 1581
2018
Q4
$122K Buy
+15,172
New +$122K ﹤0.01% 1502
2018
Q3
Sell
-14,835
Closed -$85K 1464
2018
Q2
$85K Buy
14,835
+1,646
+12% +$9.43K ﹤0.01% 1668
2018
Q1
$63K Sell
13,189
-171
-1% -$817 ﹤0.01% 1554
2017
Q4
$66K Buy
13,360
+3,171
+31% +$15.7K ﹤0.01% 1595
2017
Q3
$53K Buy
+10,189
New +$53K ﹤0.01% 1541